Revati Shreeniwas

Revati Shreeniwas

President bij
Revati, Inc.
65 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Revati Shreeniwas is President at Revati, Inc. since 2004.
Also a Member at Continuing Medical Education, Inc. Former roles include Principal at Scios, Inc., CV Therapeutics, Inc., and The Trustees of Columbia University in The City of New York.
Served as Vice President-Clinical Research & Development at Alvine Pharmaceuticals, Inc. Vice President-Clinical Development at Soleno Therapeutics, Inc. from 2019 to 2020.
Professor at Stanford University.
Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017 and at Bright Minds Biosciences, Inc. from 2020 to 2022.

Actieve functies van Revati Shreeniwas

BedrijvenFunctieBegin
Corporate Officer/Principal -
Revati, Inc.
President 01-01-2004

Eerdere bekende functies van Revati Shreeniwas

BedrijvenFunctieEinde
BRIGHT MINDS BIOSCIENCES INC. Hoofd Techniek/Wetenschap/O&O 01-12-2022
SOLENO THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 01-06-2020
Hoofd Techniek/Wetenschap/O&O 01-01-2017
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Revati Shreeniwas in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

4

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Health Technology

Revati, Inc.

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

  1. Beurs
  2. Insiders
  3. Revati Shreeniwas